Observational studyEuropean journal of heart failure2025
Lung ultrasound and mortality in a cardiogenic shock population: A prospective registry-based analysis.
Observational study in European journal of heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of PoCUS in the Diagnosis and Early Monitoring of Cardiogenic Shock in the Emergency Department: A Narrative Review.Reviews in cardiovascular medicine · 2026Review
- The rise of point-of-care ultrasound in cardiopulmonary diagnostics.European heart journal. Imaging methods and practice · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsLung ultrasound (LUS) is a widely used technique to assess de-aeration in critically ill patients with respiratory failure. There is paucity of data on LUS in cardiogenic shock (CS). We sought to evaluate the epidemiology of lung congestion and its relation with outcome. METHODS AND
resultsThe Altshock-2 registry is a multicentre, prospective, observational registry including all-comer CS patients. The LUS protocol included the examination of four zones using dichotomous assessment of lung congestion severity: ≤50% or >50%. LUS was performed at admission and at 24 h. Univariate and multivariate logistic regression analyses were performed. Overall, 185 patients (mean age 64.2 ± 13.5 years; 25.9% female) had a LUS at admission. A total of 128 patients (69.2%) had ≥50% of the investigated lung field with B-lines. At univariate Cox regression analysis, B-lines ≥50% at 24 h were significantly associated with increased 30-day mortality (hazard ratio [HR] 4.705; 95% confidence interval [CI] 2.329-9.508) and the reduction of B-lines during 24 h was associated with lower 30-day mortality (HR 0.739; 95% CI 0.571-0.956; p = 0.021). Results were confirmed at multivariate analysis after adjustment for significant covariates: B-lines ≥50% at 24 h (HR 2.23; 95% CI 1.042-8.654; p = 0.041) and the reduction in B-lines from baseline to 24 h (HR 0.815; 95% CI 0.415-1.132; p = 0.039). The sensitivity analysis, excluding patients with cardiac arrest, led to significantly increased accuracy in outcome prediction.
conclusionAssessment and monitoring of lung congestion with LUS over the first 24 h in patients with CS allow to further stratify clinical outcomes with higher accuracy when added to SCAI classification, especially when excluding patients with cardiac arrest at CS presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.